Inaba Satoshi, Okumura Hisatoshi, Aoki Tatsuya, Kawashima Atsushi
Department of General Internal Medicine Fukuchiyama City Hospital.
Department of General Medicine and Community Healthcare Kyoto Prefectural University of Medicine.
J Gen Fam Med. 2025 Jan 3;26(2):166-168. doi: 10.1002/jgf2.769. eCollection 2025 Mar.
Calcineurin inhibitor-induced pain syndrome (CIPS) is a rare but serious condition characterized by severe lower leg pain, often associated with elevated tacrolimus (TAC) levels. We report the case of a 57-year-old woman with rheumatoid arthritis (RA) who developed CIPS following a drug interaction between TAC and clarithromycin (CAM), a common macrolide antibiotic. Discontinuation of TAC led to a rapid resolution of symptoms. This case highlights the importance of monitoring TAC levels and being cautious of drug interactions, especially in primary care settings, to prevent adverse events like CIPS.
钙调神经磷酸酶抑制剂诱导的疼痛综合征(CIPS)是一种罕见但严重的病症,其特征为严重的小腿疼痛,常与他克莫司(TAC)水平升高有关。我们报告了一例57岁类风湿关节炎(RA)女性患者的病例,该患者在TAC与常见大环内酯类抗生素克拉霉素(CAM)发生药物相互作用后出现了CIPS。停用TAC后症状迅速缓解。该病例强调了监测TAC水平以及谨慎对待药物相互作用的重要性,尤其是在初级保健环境中,以预防像CIPS这样的不良事件。